Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Valvular Heart Disease

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 265 articles: HTML format

Single Articles

September 2025
1. LUNZE FI, Dusenbery SM, Gauvreau K, Lee JM, et al
   Mid-term ventricular function in patients with tetralogy of Fallot after transcatheter pulmonary valve replacement: Relationship to baseline right ventricular loading conditions.
   Int J Cardiol. 2025;434:133305.
   PubMed     Abstract available
   
   
   August 2025
2. SHI W, Wang M, Niu G, Zhao Z, et al
   Management of TAVR in asymptomatic or minimally symptomatic patients: Insights from resting angiographic microvascular resistance.
   Int J Cardiol. 2025;432:133263.
   PubMed     Abstract available
   
   
   July 2025
3. XU Z, Chen L, Dai X, Lin Z, et al
   Midterm outcomes of thoracoscopic trans-mitral myectomy for hypertrophic obstructive cardiomyopathy: A single-center, observational study.
   Int J Cardiol. 2025;430:133216.
   PubMed     Abstract available
   
   
   June 2025
4. CELEGHIN R, Pilichou K
   Mitral valve prolapse: A clinical puzzle in search of molecular solutions.
   Int J Cardiol. 2025 Jun 30:133563. doi: 10.1016/j.ijcard.2025.133563.
   PubMed    
   
   
   
5. REN CB, van den Dorpel MMP, Geleijnse M, van Mieghem NM, et al
   How accurate is intraprocedural transthoracic echocardiography in assessing aortic regurgitation after transcathether aortic valve implantation? A single center experience.
   Int J Cardiol. 2025;438:133565.
   PubMed     Abstract available
   
   
   
6. SONG Y, Ma F, Bao X, Liu Y, et al
   Letter to editor: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
   Int J Cardiol. 2025 Jun 25:133560. doi: 10.1016/j.ijcard.2025.133560.
   PubMed    
   
   
   
7. BARILI F, Pollari F, Marin-Cuartas M, Anselmi A, et al
   Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysis.
   Int J Cardiol. 2025 Jun 24:133524. doi: 10.1016/j.ijcard.2025.133524.
   PubMed     Abstract available
   
   
   
8. SCHOPS LB, Truong S, Petersen J, Alhakak A, et al
   Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
   Int J Cardiol. 2025;438:133552.
   PubMed     Abstract available
   
   
   
9. SCHREURS BA, van Kimmenade RRJ, Eijsvogels TMH
   Reply by Schreurs et al. to letter regarding article: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
   Int J Cardiol. 2025 Jun 20:133545. doi: 10.1016/j.ijcard.2025.133545.
   PubMed    
   
   
   
10. IMRAN A, Haider A
    Comment on "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study".
    Int J Cardiol. 2025;438:133534.
    PubMed    
    
    
    
11. AWAD DM
    Bridging the Gap: Addressing the Underuse of Transcatheter Edge-to-Edge Repair in Chinese Patients with Significant Mitral Regurgitation.
    Int J Cardiol. 2025;438:133519.
    PubMed    
    
    
    
12. VESELKA J, Hansvenclova E, Tesarkova KH, Januska J, et al
    Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;429:133145.
    PubMed     Abstract available
    
    
    
13. LORENZATTI A
    Cholesterol and Valvular heart disease: Is Lipoprotein(a) the sole culprit?
    Int J Cardiol. 2025;437:133510.
    PubMed    
    
    
    
14. TREMAMUNNO G, De Santis D, Santangeli C, Bona GG, et al
    Comparative analysis of pre-transcatheter aortic valve implantation CTA protocols: Optimizing radiation dose and contrast volume.
    Int J Cardiol. 2025;437:133514.
    PubMed     Abstract available
    
    
    May 2025
15. LORETZ L, Kim WK, de Backer O, Brunner S, et al
    PVL in ACURATE neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement - A multicenter retrospective registry analysis.
    Int J Cardiol. 2025;436:133428.
    PubMed     Abstract available
    
    
    
16. TRUONG S, Fosbol E, Ostergaard L
    Reply to "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective".
    Int J Cardiol. 2025 May 27:133431. doi: 10.1016/j.ijcard.2025.133431.
    PubMed    
    
    
    
17. NONAKA H, Asami M, Horiuchi Y, Tanaka J, et al
    Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registry.
    Int J Cardiol. 2025 May 27:133427. doi: 10.1016/j.ijcard.2025.133427.
    PubMed     Abstract available
    
    
    
18. EBRAHIMI S
    Early aortic valve replacement in asymptomatic severe aortic stenosis: A turning point in management.
    Int J Cardiol. 2025;435:133411.
    PubMed    
    
    
    
19. BLACKMAN DJ, Aktaa S, Pickles D, Abdel-Wahab M, et al
    REdo transcatheter aortic VALVE implantation for the management of transcatheter aortic valve failure: Design and rationale of the REVALVE study.
    Int J Cardiol. 2025 May 18:133400. doi: 10.1016/j.ijcard.2025.133400.
    PubMed     Abstract available
    
    
    
20. HASSAN SAU, Huda NU, Maheen M
    Letter to the editor: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025;435:133392.
    PubMed    
    
    
    
21. JABRI A, Suri RM, Villablanca P
    Redo or Redon't? Mitral valve reoperation vs. first-time surgery outcomes: A nationwide study.
    Int J Cardiol. 2025;434:133353.
    PubMed    
    
    
    
22. FATH AR, Aglan A, Maron MS, Phillips JS, et al
    Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;426:133082.
    PubMed     Abstract available
    
    
    April 2025
23. CHEN B, Wang C, Li W
    Comprehensive genetic analysis based on multi - omics reveals novel therapeutic targets for mitral valve prolapse and drug molecular dynamics simulation.
    Int J Cardiol. 2025 Apr 29:133325. doi: 10.1016/j.ijcard.2025.133325.
    PubMed     Abstract available
    
    
    
24. SCHREURS BA, van der Sluijs KM, Hopman MTE, Bakker EA, et al
    Physical activity characteristics in adults with bicuspid aortic valve versus age- and sex-matched controls.
    Int J Cardiol. 2025 Apr 29:133330. doi: 10.1016/j.ijcard.2025.133330.
    PubMed     Abstract available
    
    
    
25. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
    Reply to: Correction to external evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
    Int J Cardiol. 2025;433:133310.
    PubMed    
    
    
    
26. WEI P, Zhao G, Dong J, Feng S, et al
    Anatomical suitability and clinical outcomes of transcatheter edge-to-edge repair in Chinese patients with significant mitral regurgitation: A real-world echocardiographic study.
    Int J Cardiol. 2025;433:133317.
    PubMed     Abstract available
    
    
    
27. MAYNTZ SP, Davidovski FS
    Improving gender-specific management of aortic stenosis with IMPULSE registry data.
    Int J Cardiol. 2025;433:133293.
    PubMed    
    
    
    
28. SITGES M
    Improving our management of tricuspid regurgitation: present and future opportunities.
    Int J Cardiol. 2025 Apr 18:133288. doi: 10.1016/j.ijcard.2025.133288.
    PubMed    
    
    
    
29. MCDONOUGH RV
    Correction to: External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard (Int J Cardiol. 2025;419:132653).
    Int J Cardiol. 2025;432:133260.
    PubMed    
    
    
    
30. JACQUEMYN X, Sa MP, Marin-Cuartas M, Bax JJ, et al
    Early aortic valve replacement versus conservative management in asymptomatic severe aortic stenosis: Meta-analysis of time-to-event data of randomized controlled trials.
    Int J Cardiol. 2025;432:133269.
    PubMed     Abstract available
    
    
    
31. IFTIKHAR MK, Iftikhar QUA, Baig MMA
    Mitral valve reoperation: Refining risk stratification for better outcomes.
    Int J Cardiol. 2025;431:133239.
    PubMed    
    
    
    
32. JAVED MN, Ahmed U, Eman NU
    Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective.
    Int J Cardiol. 2025;431:133238.
    PubMed    
    
    
    March 2025
33. BLEIZIFFER S, Messika-Zeitoun D, Steeds R, Appleby C, et al
    Gender differences in the presentation and management of patients with severe aortic stenosis at specialist versus primary/sondary care centres: A sub-analysis of the IMPULSE enhanced registry.
    Int J Cardiol. 2025 Mar 30:133223. doi: 10.1016/j.ijcard.2025.133223.
    PubMed     Abstract available
    
    
    
34. LUO D, Bjornson E, Wang X, Zhang B, et al
    Distinct lipoprotein contributions to valvular heart disease: Insights from genetic analysis.
    Int J Cardiol. 2025 Mar 27:133218. doi: 10.1016/j.ijcard.2025.133218.
    PubMed     Abstract available
    
    
    
35. TRUONG S, Petersen J, Havers-Borgersen E, Schops LB, et al
    Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
    Int J Cardiol. 2025 Mar 18:133175. doi: 10.1016/j.ijcard.2025.133175.
    PubMed     Abstract available
    
    
    
36. CAI Y, Ou M, Li Y, Zhang X, et al
    Parameters of speckle tracking echocardiography in right atrial fibrosis of patients with rheumatic mitral stenosis: Focusing on right atrial stiffness.
    Int J Cardiol. 2025;429:133170.
    PubMed     Abstract available
    
    
    
37. LAI Q, Wei Z, Zhang X, Li Q, et al
    The passability of delivery catheter system during self-expanding transcatheter aortic valve replacement: A CT-based prediction model.
    Int J Cardiol. 2025 Mar 16:133168. doi: 10.1016/j.ijcard.2025.133168.
    PubMed     Abstract available
    
    
    
38. GODINO C, Nemola G, Sisinni A, Margonato D, et al
    Therapeutical approach of tricuspid regurgitation and right heart failure.
    Int J Cardiol. 2025;429:133163.
    PubMed     Abstract available
    
    
    
39. SONAGLIONI A, Nicolosi GL, Lombardo M
    Navigating the prognostic risk stratification of moderate and severe asymptomatic aortic stenosis.
    Int J Cardiol. 2025;429:133141.
    PubMed    
    
    
    
40. AHMED A, Safiriyu I, Kaddoura R, Mohyeldin M, et al
    Outcomes of transcatheter aortic valve implantation in Africa: A systematic review and meta-analysis.
    Int J Cardiol. 2025 Mar 10:133139. doi: 10.1016/j.ijcard.2025.133139.
    PubMed     Abstract available
    
    
    
41. PANCALDI E, Adamo M, Pagnesi M, Russo G, et al
    Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Mar 9:133137. doi: 10.1016/j.ijcard.2025.133137.
    PubMed     Abstract available
    
    
    
42. TAKAHARI K, Utsunomiya H, Tohgi K, Hamada A, et al
    Tissue-tracking mitral annular displacement predicts impaired left ventricular mechanics and adverse outcomes in aortic stenosis with preserved left ventricular ejection fraction.
    Int J Cardiol. 2025 Mar 2:133106. doi: 10.1016/j.ijcard.2025.133106.
    PubMed     Abstract available
    
    
    
43. FERRI LA, Ancona MB, Papageorgiou C, Vella C, et al
    Computed tomography derived predictors of left ventricular obstruction after TAVR.
    Int J Cardiol. 2025;422:132956.
    PubMed     Abstract available
    
    
    
44. KHAN S, Demir O, Mehmood M, Nabi I, et al
    An automated method of streamlining waiting list by clinical risk fast-tracking for patients awaiting TAVR: SWIFT TAVR algorithm.
    Int J Cardiol. 2025;422:132952.
    PubMed     Abstract available
    
    
    
45. SCHOONVELDE SAC, Alexandridis GM, Price LB, Schinkel AFL, et al
    Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.
    Int J Cardiol. 2025;422:132951.
    PubMed     Abstract available
    
    
    February 2025
46. AKITA K, Suwa K, Ohno K, Weiner SD, et al
    Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2025;421:132911.
    PubMed     Abstract available
    
    
    
47. GULER A, Erata YE, Demirtola AI, Turkmen I, et al
    The effect of disopyramide therapy on functional capacity improvement in patients with obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;421:132913.
    PubMed     Abstract available
    
    
    
48. ZENG X, Wu H, Wang R, Huang P, et al
    Major adverse cardiovascular events after modified morrow surgery in hypertrophic obstructive cardiomyopathy: A 12-year cohort study.
    Int J Cardiol. 2025;421:132864.
    PubMed     Abstract available
    
    
    
49. ABBAS MT, Farina JM, Awad K, Badr A, et al
    The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degeneration.
    Int J Cardiol. 2025;425:133067.
    PubMed     Abstract available
    
    
    
50. KOLIASTASIS L, Kim WK
    Coronary physiology assessment in severe aortic stenosis: Feasible yet challenging.
    Int J Cardiol. 2025 Feb 13:133063. doi: 10.1016/j.ijcard.2025.133063.
    PubMed    
    
    
    January 2025
51. ALNABTI A, Abujalala S, Al-Hijji M, Othman K, et al
    Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) -first report 24/7/2024.
    Int J Cardiol. 2025 Jan 29:133029. doi: 10.1016/j.ijcard.2025.133029.
    PubMed     Abstract available
    
    
    
52. TUSA M, Amicone S
    Rediscovering racial disparities in tricuspid regurgitation: A call for increased and targeted treatment approach.
    Int J Cardiol. 2025 Jan 25:133007. doi: 10.1016/j.ijcard.2025.133007.
    PubMed    
    
    
    
53. LU T, Zhu C, Cui H, Meng Y, et al
    Preoperative D-dimer and outcomes in obstructive hypertrophic cardiomyopathy after myectomy.
    Int J Cardiol. 2025;419:132705.
    PubMed     Abstract available
    
    
    
54. JENSEN RV, Jensen JM, Iraqi N, Grove EL, et al
    Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
    Int J Cardiol. 2025;419:132694.
    PubMed     Abstract available
    
    
    
55. ZHANG L, Ding F, Ren Z, Cheng W, et al
    Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant.
    Int J Cardiol. 2025;419:132627.
    PubMed     Abstract available
    
    
    
56. KIM M, Seo J, Kim IS, Cho S, et al
    Differential determinants and prognostic value of aortic valve sclerosis over carotid atherosclerosis.
    Int J Cardiol. 2025 Jan 11:132980. doi: 10.1016/j.ijcard.2025.132980.
    PubMed     Abstract available
    
    
    
57. KAGAMI K, Kagiyama N, Kaneko T, Harada T, et al
    Heart failure with preserved ejection fraction in atrial functional mitral regurgitation - Insight from the REVEAL-AFMR.
    Int J Cardiol. 2025;422:132958.
    PubMed     Abstract available
    
    
    December 2024
58. GAMARRA-VALVERDE NN, Masket D, Henry ML, Mares AC, et al
    Anticoagulation therapy for the prevention of subclinical leaflet thrombosis after transcatheter aortic valve replacement: A comprehensive literature review and future directions.
    Int J Cardiol. 2024 Dec 28:132946. doi: 10.1016/j.ijcard.2024.132946.
    PubMed     Abstract available
    
    
    
59. ALBULUSHI A, Al-Abri U, Al Matrooshi N, Alsabti H, et al
    Pulmonary hypertension as a prognostic marker in low-flow low-gradient aortic stenosis: Insights from invasive hemodynamics and post-TAVR outcomes.
    Int J Cardiol. 2024;421:132910.
    PubMed     Abstract available
    
    
    
60. MUSHTAQ S, Chiesa M, Novelli V, Sommariva E, et al
    Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;417:132554.
    PubMed     Abstract available
    
    
    
61. HAGEGE A, Puscas T, El Hachmi M, Parodi A, et al
    The French hypertrophic cardiomyopathy gene register: A systematic large gene screening for hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;417:132542.
    PubMed     Abstract available
    
    
    
62. CORCIONE N, Ferraro P, Finizio F, Cimmino M, et al
    Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation.
    Int J Cardiol. 2024;421:132874.
    PubMed     Abstract available
    
    
    
63. CESMAT AP, Chaudry AM, Gupta S, Weickert TT, et al
    Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.
    Int J Cardiol. 2024;421:132888.
    PubMed     Abstract available
    
    
    
64. ECHARTE-MORALES J, Scotti A, Bonnet G, Torrado J, et al
    Racial and ethnic disparities in patients with severe tricuspid regurgitation: The Bronx-Valve registry.
    Int J Cardiol. 2024;421:132889.
    PubMed     Abstract available
    
    
    
65. SAIJO Y, Okushi Y, Gillinov AM, Pettersson GB, et al
    Sex-related differences in outcomes and prognosis of severe calcific mitral stenosis due to mitral annular calcification: A propensity-score matched cohort study.
    Int J Cardiol. 2024;421:132893.
    PubMed     Abstract available
    
    
    
66. KIM WK, Bleiziffer S
    Are there sex-specific disparities in transcatheter aortic valve implantation?
    Int J Cardiol. 2024;421:132882.
    PubMed    
    
    
    
67. PANG S, Wu J, Ke Y, Wang Q, et al
    Letter to the Editor: Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
    Int J Cardiol. 2024;421:132883.
    PubMed    
    
    
    
68. YAN T, Weng F, Guo C
    miR-124-3p may exert its effects in hypertrophic cardiomyopathy by inhibiting cardiomyocyte apoptosis.
    Int J Cardiol. 2024;416:132470.
    PubMed    
    
    
    November 2024
69. FEZZI S, Pesarini G, Flaim M, Ding D, et al
    Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI.
    Int J Cardiol. 2024 Nov 25:132761. doi: 10.1016/j.ijcard.2024.132761.
    PubMed     Abstract available
    
    
    
70. HAFIANE A, Pisaturo A, Favari E, Bortnick AE, et al
    Atherosclerosis, calcific aortic valve disease and mitral annular calcification: Same or different?
    Int J Cardiol. 2024 Nov 16:132741. doi: 10.1016/j.ijcard.2024.132741.
    PubMed     Abstract available
    
    
    
71. BERGHMANS S, Eyskens B, Rega F, Moons P, et al
    A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs.
    Int J Cardiol. 2024;415:132476.
    PubMed     Abstract available
    
    
    
72. SANNA GD, Finocchiaro G
    Sarcomere gene mutations in hypertrophic cardiomyopathy: how to clinically manage this information?
    Int J Cardiol. 2024;415:132373.
    PubMed    
    
    
    
73. BONAVENTURA J, Maron BJ
    Chasing the molecular background of hypertrophic cardiomyopathy: The continuing saga to predict adverse outcomes with sarcomere mutations.
    Int J Cardiol. 2024;415:132366.
    PubMed    
    
    
    
74. PEREIRA AR, Al Jaff AAM, Cabezas JM, de Weger A, et al
    Unilateral-access vs. bilateral-access in transfemoral transcatheter aortic valve replacement: A slim fit approach.
    Int J Cardiol. 2024 Nov 14:132712. doi: 10.1016/j.ijcard.2024.132712.
    PubMed     Abstract available
    
    
    
75. ABRAHAM B, Sous M, Kaldas S, Nakhla M, et al
    Transcaval access for transcatheter aortic valve implantation: A meta-analysis and systematic review.
    Int J Cardiol. 2024 Nov 11:132720. doi: 10.1016/j.ijcard.2024.132720.
    PubMed     Abstract available
    
    
    
76. LIN S, Zhang Y, Wang S, Ding X, et al
    Prognostic utility of dynamic changes in epicardial adipose tissue in patients undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2024 Nov 10:132697. doi: 10.1016/j.ijcard.2024.132697.
    PubMed     Abstract available
    
    
    
77. EL MATHARI S, Hopman LHGA, Bouchnaf C, Heidendael JF, et al
    Clinical implications of different methods to assess left atrial remodeling: A comparative study between echocardiography and cardiac magnetic resonance imaging for left atrial volume index quantification.
    Int J Cardiol. 2024;414:132443.
    PubMed     Abstract available
    
    
    
78. FERNANDEZ A, Niel N, Parma G, Loza G, et al
    Warfarin use is associated with higher aortic bioprosthetic 18F-fluoride PET uptake.
    Int J Cardiol. 2024;414:132394.
    PubMed     Abstract available
    
    
    October 2024
79. YANG Y, Ye Y
    Women: More susceptible to develop unfavorable in-hospital outcomes after transcatheter aortic valve replacement.
    Int J Cardiol. 2024 Oct 22:132678. doi: 10.1016/j.ijcard.2024.132678.
    PubMed    
    
    
    
80. ALPERI A, Avanzas P
    TAVR in tapered raphe-type stenotic bicuspid aortic valves: excellent results in challenging anatomies.
    Int J Cardiol. 2024 Oct 19:132656. doi: 10.1016/j.ijcard.2024.132656.
    PubMed    
    
    
    
81. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
    External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
    Int J Cardiol. 2024 Oct 19:132653. doi: 10.1016/j.ijcard.2024.132653.
    PubMed     Abstract available
    
    
    
82. FIGLIOZZI S, Masci PG, Monti L, Stankowski K, et al
    Prognostic value of right ventricular involvement in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2024;413:132390.
    PubMed     Abstract available
    
    
    
83. KUMAR M, Hu JR, Ali S, Khlidj Y, et al
    Sex disparities in outcomes of transcatheter aortic valve implantation- a multi-year propensity-matched nationwide study.
    Int J Cardiol. 2024;418:132619.
    PubMed     Abstract available
    
    
    
84. TRUONG S, Petersen J, Schmiegelow MDS, Due H, et al
    Incidence and factors associated with mitral valve reoperation in patients undergoing surgery for mitral regurgitation: A nationwide cohort study.
    Int J Cardiol. 2024;418:132608.
    PubMed     Abstract available
    
    
    September 2024
85. SAITO T, Tsuruta H, Iwata J, Kajino A, et al
    Impact of beta-blocker uptitration on patients after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation: The OCEAN-mitral registry.
    Int J Cardiol. 2024 Sep 24:132595. doi: 10.1016/j.ijcard.2024.132595.
    PubMed     Abstract available
    
    
    
86. BUONO A, De Biase C, Fabris T, Bellamoli M, et al
    CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry.
    Int J Cardiol. 2024 Sep 18:132569. doi: 10.1016/j.ijcard.2024.132569.
    PubMed     Abstract available
    
    
    
87. HARIKRISHNAN S, Koshy L, Ganapathi S, Jeemon P, et al
    Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;411:132273.
    PubMed     Abstract available
    
    
    
88. BANSAL S, Gupta A
    TAVR outcomes in females - What is changing!
    Int J Cardiol. 2024;411:132247.
    PubMed    
    
    
    
89. ABU-MUCH A, Grines CL, Chen S, Batchelor WB, et al
    Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
    Int J Cardiol. 2024;417:132555.
    PubMed     Abstract available
    
    
    
90. PISKLOVA M, Osmak G
    Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.
    Int J Cardiol. 2024;410:132220.
    PubMed     Abstract available
    
    
    
91. GOMEZ-HERRERO J, Fernandez-Cordon C, Gonzalez JC, Garcia-Gomez M, et al
    TAV-in-TAV in patients with prosthesis embolization: Impact of commissural alignment and global outcomes.
    Int J Cardiol. 2024;410:132179.
    PubMed     Abstract available
    
    
    August 2024
92. MARGONATO D
    The therapeutical role of balloon aortic valvuloplasty: Back to the origin?
    Int J Cardiol. 2024 Aug 28:132493. doi: 10.1016/j.ijcard.2024.132493.
    PubMed    
    
    
    
93. BONFIOLI GB, Pagnesi M
    Pulmonary vein flow pattern: A marker of successful repair in primary mitral regurgitation?
    Int J Cardiol. 2024 Aug 28:132498. doi: 10.1016/j.ijcard.2024.132498.
    PubMed    
    
    
    
94. LAI KY, Lee CY, Chang YC, Liu K, et al
    Prognostic value of fully-automated left atrial strain in patients with asymptomatic chronic severe aortic regurgitation.
    Int J Cardiol. 2024 Aug 27:132487. doi: 10.1016/j.ijcard.2024.132487.
    PubMed     Abstract available
    
    
    
95. LIU T, Yang X, Jia R, Han J, et al
    Left atrial mechanical dispersion and left atrial stiffness predicts recurrence of atrial fibrillation: In patients with moderate-severe rheumatic mitral stenosis.
    Int J Cardiol. 2024 Aug 26:132480. doi: 10.1016/j.ijcard.2024.132480.
    PubMed     Abstract available
    
    
    
96. HUANG Z, Lin K, Huang J, Chen Y, et al
    Characteristics and outcomes associated with sarcomere mutations in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2024;409:132213.
    PubMed     Abstract available
    
    
    
97. FAN J, Li Z, Lin D, Miao J, et al
    Long-term outcomes in patients with bicuspid valve stenosis and aortic dilation undergoing transcatheter valve implantation.
    Int J Cardiol. 2024;409:132201.
    PubMed     Abstract available
    
    
    
98. FAGGI A, Denti P
    Contemporary TAVI counterindications and space for staged procedures.
    Int J Cardiol. 2024;409:132172.
    PubMed    
    
    
    
99. NASIR MM, Amir S, Shahid A, Rehman WU, et al
    Valve-in-valve transcatheter mitral valve replacement versus redo-surgical mitral valve replacement for degenerated bioprosthetic mitral valves: A systematic review and meta-analysis.
    Int J Cardiol. 2024;415:132448.
    PubMed     Abstract available
    
    
    
100. AMSALEM I, Carasso S
     Increased utilization of mitral transcatheter edge-to-edge repair in degenerative mitral regurgitation: The essential need for better prognostic and procedural success tools.
     Int J Cardiol. 2024 Aug 14:132457. doi: 10.1016/j.ijcard.2024.132457.
     PubMed    
     
     
     
101. GE Z, Ge Z, Hu C, Wang Y, et al
     Characteristic of myocardial work in mitral valve prolapse with versus without mitral annular disjunction: A propensity-matched study.
     Int J Cardiol. 2024 Aug 6:132434. doi: 10.1016/j.ijcard.2024.132434.
     PubMed     Abstract available
     
     
     
102. YEDIDYA I, Stassen J, Butcher S, van Wijngaarden AL, et al
     The prognostic value of changes in pulmonary vein flow patterns after surgical repair for primary mitral regurgitation.
     Int J Cardiol. 2024;414:132414.
     PubMed     Abstract available
     
     
     
103. YAGI N, Hasegawa H, Kuwajima K, Ogawa M, et al
     Indexed aortic valve area using multimodality imaging for assessing the severity of bicuspid aortic stenosis.
     Int J Cardiol. 2024;414:132416.
     PubMed     Abstract available
     
     
     
104. SPRINGHETTI P, Tomaselli M, Clavel MA
     Measuring the aortic valvular area: Key challenges in aortic stenosis assessment.
     Int J Cardiol. 2024;414:132410.
     PubMed    
     
     
     
105. LORCA R, Salgado M, Alvarez-Velasco R, Reguro JR, et al
     Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing.
     Int J Cardiol. 2024;408:132117.
     PubMed     Abstract available
     
     
     
106. TONDI L, Pica S, Crimi G, Disabato G, et al
     "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
     Int J Cardiol. 2024;408:132135.
     PubMed     Abstract available
     
     
     
107. BESOLA L, Falcetta G, Ceravolo G, Fiocco A, et al
     New echocardiographic screening tool for left ventricular tract obstruction risk assessment in TMVR.
     Int J Cardiol. 2024;408:132112.
     PubMed     Abstract available
     
     
     July 2024
108. HUSSAIN B, Tarabanis C, Aslam MMS, Dhulipala V, et al
     Inpatient outcomes of mechanical circulatory support devices and heart transplantation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;413:132396.
     PubMed     Abstract available
     
     
     
109. RAHOUMA M, Khairallah S, Lau C, Al Zghari T, et al
     The impact of comorbidities on outcomes of concomitant mitral valve intervention with ascending aortic surgery.
     Int J Cardiol. 2024;413:132398.
     PubMed     Abstract available
     
     
     
110. KELLY B, Thorup L, Telinius N, Mohanakumar S, et al
     Lymphatic morphology and function in chronic right heart failure due to secondary tricuspid valve regurgitation.
     Int J Cardiol. 2024;413:132399.
     PubMed     Abstract available
     
     
     
111. TOMSIC A, Holubec T, Sandoval E, Pham T, et al
     Mitral valve repair with resection and non-resection techniques in Barlow's disease: A multi-center study.
     Int J Cardiol. 2024 Jul 22:132387. doi: 10.1016/j.ijcard.2024.132387.
     PubMed     Abstract available
     
     
     
112. DE FELICE F, Musto C, Paolucci L
     TAVR in bicuspid aortic valve and ascending aorta dilatation: sitting on a fence or jumping on the bandwagon.
     Int J Cardiol. 2024 Jul 19:132372. doi: 10.1016/j.ijcard.2024.132372.
     PubMed    
     
     
     
113. AMADOR AF
     Edmonton frail scale in TAVI patients: A new tool for frailty assessment and outcomes prediction.
     Int J Cardiol. 2024;407:132024.
     PubMed    
     
     
     
114. DAYAN V, Fernandez A, Loza G, Parma G, et al
     Early anticoagulation after aortic valve replacement with porcine bioprosthesis randomized control trial(ANTIPRO). 3?years follow-up.
     Int J Cardiol. 2024 Jul 12:132361. doi: 10.1016/j.ijcard.2024.132361.
     PubMed     Abstract available
     
     
     
115. ALBANI S, Merlo M
     Left ventricle late gadolinium enhancement and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy: Another brick towards a precise approach.
     Int J Cardiol. 2024;413:132357.
     PubMed    
     
     
     
116. LOFFI M, Adamo M, Rubbio AP, Pezzola E, et al
     Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair.
     Int J Cardiol. 2024 Jul 8:132317. doi: 10.1016/j.ijcard.2024.132317.
     PubMed     Abstract available
     
     
     
117. FUJIMOTO T, Zen K, Kataoka E, Kitada T, et al
     Balloon aortic valvuloplasty bridge to transcatheter aortic valve replacement is associated with worse in-hospital mortality.
     Int J Cardiol. 2024 Jul 6:132348. doi: 10.1016/j.ijcard.2024.132348.
     PubMed     Abstract available
     
     
     
118. OMAR P, Giovanni B, Williams J, Thomas F, et al
     Quantification of anatomical aortic valve area by multi-detector computed tomography: A pilot 3D-morphological modeling of the stenotic aortic valve.
     Int J Cardiol. 2024 Jul 6:132322. doi: 10.1016/j.ijcard.2024.132322.
     PubMed     Abstract available
     
     
     
119. HEEGER CH, Alagjozovski H
     Editorial to: Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
     Int J Cardiol. 2024;412:132299.
     PubMed    
     
     
     
120. BONANNI M, Russo G, De Siati M, Tomao F, et al
     Holographic mixed reality for planning transcatheter aortic valve replacement.
     Int J Cardiol. 2024 Jul 2:132330. doi: 10.1016/j.ijcard.2024.132330.
     PubMed     Abstract available
     
     
     
121. TIRADO-CONTE G, Pardo Sanz A, Salido Tahoces L
     Ascending aortic dilatation in TAVI: Actor or bystander?
     Int J Cardiol. 2024;406:132089.
     PubMed    
     
     
     June 2024
122. RUSSO G, Hahn RT, Alessandrini H, Andreas M, et al
     Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry.
     Int J Cardiol. 2024;405:131934.
     PubMed     Abstract available
     
     
     
123. LV J, Wu Y, Xu H
     Transcatheter mitral valve intervention in patients with cancer: More efforts are needed.
     Int J Cardiol. 2024 Jun 15:132271. doi: 10.1016/j.ijcard.2024.132271.
     PubMed    
     
     
     
124. HOLLOWELL M, Banno J, Marsy D, Shrestha N, et al
     Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024 Jun 13:132263. doi: 10.1016/j.ijcard.2024.132263.
     PubMed     Abstract available
     
     
     
125. ALPERI A, Pascual I, Moris C, Avanzas P, et al
     Valve-in-valve after transcatheter aortic valve embolization: Do we need to align the commissures?
     Int J Cardiol. 2024 Jun 11:132255. doi: 10.1016/j.ijcard.2024.132255.
     PubMed    
     
     
     
126. D'AMARIO D, Laborante R, Mennuni M, Adamo M, et al
     Efficacy and safety of trans-catheter repair devices for mitral regurgitation: A systematic review and meta-analysis.
     Int J Cardiol. 2024 Jun 6:132245. doi: 10.1016/j.ijcard.2024.132245.
     PubMed     Abstract available
     
     
     
127. AYYAD M, Jabri A, Khalefa BB, Al-Abdouh A, et al
     Efficacy and safety of TAVR versus SAVR in patients with small aortic annuli: A systematic review and meta-analysis.
     Int J Cardiol. 2024 Jun 6:132243. doi: 10.1016/j.ijcard.2024.132243.
     PubMed     Abstract available
     
     
     
128. KIRCHNER J, Gercek M, Gesch J, Omran H, et al
     Artificial intelligence-analyzed computed tomography in patients undergoing transcatheter tricuspid valve repair.
     Int J Cardiol. 2024 Jun 5:132233. doi: 10.1016/j.ijcard.2024.132233.
     PubMed     Abstract available
     
     
     
129. SUNAGA A, Matsuoka Y, Nakatani D, Okada K, et al
     Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
     Int J Cardiol. 2024 Jun 3:132231. doi: 10.1016/j.ijcard.2024.132231.
     PubMed     Abstract available
     
     
     
130. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
     Response to: Regard to assessing agreement between two raters with kappa statistics.
     Int J Cardiol. 2024;404:131978.
     PubMed    
     
     
     
131. GESKE JB, Schaff HV
     Role of experience in myectomy for hypertrophic cardiomyopathy: With very high procedural volume, myectomy remains low-risk even with concomitant procedure need.
     Int J Cardiol. 2024;404:131961.
     PubMed    
     
     
     
132. ANG SP, Chia JE
     Reevaluating female survival benefit in TAVR: A closer look in the current era.
     Int J Cardiol. 2024;404:131935.
     PubMed    
     
     
     May 2024
133. SHI W, Feng D, Hu X, Wang C, et al
     Prediction of hypoattenuating leaflet thickening in patients underwent transcatheter aortic valves replacement based on clinical factors and 4D-computed tomography morphological characteristics: A retrospective cross-sectional study.
     Int J Cardiol. 2024 May 28:132219. doi: 10.1016/j.ijcard.2024.132219.
     PubMed     Abstract available
     
     
     
134. AURIGEMMA C, Busco M, Bianchini F, Bianchini E, et al
     Clinical impact of multiple resheathing during transcatheter aortic valve implantation with Evolut self-expanding valves.
     Int J Cardiol. 2024 May 28:132218. doi: 10.1016/j.ijcard.2024.132218.
     PubMed     Abstract available
     
     
     
135. WAZZAN AAL, Taconne M, Rolle VL, Forsaa MI, et al
     Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain.
     Int J Cardiol. 2024 May 24:132167. doi: 10.1016/j.ijcard.2024.132167.
     PubMed     Abstract available
     
     
     
136. RELLA V, Maurizi N, Bernardini A, Brasca FM, et al
     Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2024 May 23:132202. doi: 10.1016/j.ijcard.2024.132202.
     PubMed     Abstract available
     
     
     
137. MARTIN M, Rozado J
     Imaging in severe aortic stenosis: Looking at the future.
     Int J Cardiol. 2024 May 16:132183. doi: 10.1016/j.ijcard.2024.132183.
     PubMed    
     
     
     
138. SEE C, Kim Y, Park J, Wang Y, et al
     High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT?
     Int J Cardiol. 2024 May 14:132174. doi: 10.1016/j.ijcard.2024.132174.
     PubMed     Abstract available
     
     
     
139. MONDA E, Boccia A, Altobelli I, Mauriello A, et al
     Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy.
     Int J Cardiol. 2024;408:132067.
     PubMed     Abstract available
     
     
     
140. VOGES I, Hansen JH
     Critical aortic stenosis - The long-term burden.
     Int J Cardiol. 2024;408:132134.
     PubMed    
     
     
     
141. ALPERI A, Pascual I, Moris C, Avanzas P, et al
     Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure.
     Int J Cardiol. 2024;402:131883.
     PubMed    
     
     
     
142. VESELKA J
     Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligence.
     Int J Cardiol. 2024;402:131842.
     PubMed    
     
     
     
143. GARAGOLI F, Chiabrando JG, Seropian IM, Lombardi M, et al
     Stroke risk after transcatheter aortic valve replacement in patients with carotid stenosis: A systematic review and meta-analysis.
     Int J Cardiol. 2024 May 1:132085. doi: 10.1016/j.ijcard.2024.132085.
     PubMed     Abstract available
     
     
     April 2024
144. QIU Y, Li M, Song X, Li Z, et al
     Predictive nomogram for 28-day mortality risk in mitral valve disorder patients in the intensive care unit: A comprehensive assessment from the MIMIC-III database.
     Int J Cardiol. 2024 Apr 25:132105. doi: 10.1016/j.ijcard.2024.132105.
     PubMed     Abstract available
     
     
     
145. LEE CY, Tsai CM, Chiang KC, Huang CC, et al
     Prognostic value of left ventricular and left atrial strain imaging in moderate to severe aortic stenosis: Insights from an Asian population.
     Int J Cardiol. 2024 Apr 25:132103. doi: 10.1016/j.ijcard.2024.132103.
     PubMed     Abstract available
     
     
     
146. CHEN B, Zhang Q
     The role of left ventricular global work index on the prediction of cardiovascular mortality after transcatheter aortic valve implantation.
     Int J Cardiol. 2024 Apr 23:132101. doi: 10.1016/j.ijcard.2024.132101.
     PubMed    
     
     
     
147. MARMAGKIOLIS K, Monlezun DJ, Caballero J, Cilingiroglu M, et al
     Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures.
     Int J Cardiol. 2024 Apr 23:132091. doi: 10.1016/j.ijcard.2024.132091.
     PubMed     Abstract available
     
     
     
148. GUO Y, Li H, Huang B, Hou L, et al
     LncRNA HOTAIR ameliorates calcific aortic valve disease by sponging miR-29b.
     Int J Cardiol. 2024 Apr 23:132094. doi: 10.1016/j.ijcard.2024.132094.
     PubMed    
     
     
     
149. GERHARDT P, Shehu N, Ferrari I, Hullebrandt M, et al
     Quantifying aortic valve regurgitation in patients with congenital aortic valve disease by 2D and 4D flow magnetic resonance analysis.
     Int J Cardiol. 2024 Apr 21:132084. doi: 10.1016/j.ijcard.2024.132084.
     PubMed     Abstract available
     
     
     
150. DAHME T
     Effects of tricuspid edge-to-edge repair beyond leaflet approximation: Evidence for indirect tricuspid annuloplasty.
     Int J Cardiol. 2024;406:132066.
     PubMed    
     
     
     
151. SADEGHIPOUR P, Mozafarybazargany M, Farrashi M, De Caterina R, et al
     Response to "Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants".
     Int J Cardiol. 2024 Apr 20:132076. doi: 10.1016/j.ijcard.2024.132076.
     PubMed    
     
     
     
152. PRAKASH SK
     Editorial on Bellino et al., "Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe".
     Int J Cardiol. 2024 Apr 16:132047. doi: 10.1016/j.ijcard.2024.132047.
     PubMed    
     
     
     
153. CHENG Y, Zhang Q
     Commentary on the mitral regurgitation outcomes after transcatheter atrial septal defect closure.
     Int J Cardiol. 2024 Apr 6:132033. doi: 10.1016/j.ijcard.2024.132033.
     PubMed    
     
     
     
154. ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
     Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;400:131790.
     PubMed     Abstract available
     
     
     
155. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
     Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
     Int J Cardiol. 2024;400:131768.
     PubMed     Abstract available
     
     
     March 2024
156. SANG SLW, Weissman C, Parker J, Timek T, et al
     Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach.
     Int J Cardiol. 2024 Mar 30:132004. doi: 10.1016/j.ijcard.2024.132004.
     PubMed     Abstract available
     
     
     
157. BELLINO M, Antonini-Canterin F, Bossone E, Faggiano P, et al
     Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe.
     Int J Cardiol. 2024 Mar 30:132000. doi: 10.1016/j.ijcard.2024.132000.
     PubMed     Abstract available
     
     
     
158. BLEIZIFFER S, Appleby C, Delgado V, Eltchaninoff H, et al
     Patterns of aortic valve replacement in Europe and adoption by sex.
     Int J Cardiol. 2024 Mar 28:131996. doi: 10.1016/j.ijcard.2024.131996.
     PubMed     Abstract available
     
     
     
159. KALKAN S, Gursoy MO, Guner A, Kalcik M, et al
     Management of prosthetic valve thrombosis with unfractionated heparin.
     Int J Cardiol. 2024 Mar 19:131968. doi: 10.1016/j.ijcard.2024.131968.
     PubMed     Abstract available
     
     
     
160. BICHUETTE LD, Lottenberg MP, Caramelli B
     Hypertrophic cardiomyopathy as a high-risk feature on perioperative care: How to deal with this self-fulfilling prophecy?
     Int J Cardiol. 2024;399:131683.
     PubMed    
     
     
     
161. ZACH DK, Schwegel N, Santner V, Winkelbauer L, et al
     Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;399:131661.
     PubMed     Abstract available
     
     
     
162. NASCIMENTO BR, Nunes MCP, da Silva JLP, Steer A, et al
     Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
     Int J Cardiol. 2024;399:131662.
     PubMed     Abstract available
     
     
     
163. FENG D, Zhao J, Niu G, Zhang Y, et al
     Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.
     Int J Cardiol. 2024 Mar 11:131948. doi: 10.1016/j.ijcard.2024.131948.
     PubMed     Abstract available
     
     
     
164. BONELLO B, Issitt R, Hughes M, Carr M, et al
     Long-term outcome after neonatal intervention for congenital critical aortic stenosis.
     Int J Cardiol. 2024 Mar 2:131932. doi: 10.1016/j.ijcard.2024.131932.
     PubMed     Abstract available
     
     
     
165. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
     Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
     Int J Cardiol. 2024;398:131601.
     PubMed     Abstract available
     
     
     
166. LIU Z, Wei P, Jiang H, Zhang F, et al
     Corrigendum to 'Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019' [Int. J. Cardiol. 395(2024) 131561].
     Int J Cardiol. 2024 Mar 1:131919. doi: 10.1016/j.ijcard.2024.131919.
     PubMed    
     
     
     February 2024
167. BOURG C, Lee KC, Donal E
     Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
     Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
     PubMed    
     
     
     
168. DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
     Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
     Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
     PubMed     Abstract available
     
     
     
169. AKHTAR KH, Pahuja M, Baber U
     Self-expanding or balloon-expandable valve for TAVR in low risk patients: The jury is still out!
     Int J Cardiol. 2024;397:131619.
     PubMed    
     
     
     
170. DE MARZO V, Zimarino M
     The value of transaxillary access for TAVI.
     Int J Cardiol. 2024;397:131448.
     PubMed    
     
     
     
171. FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
     Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
     Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
     PubMed     Abstract available
     
     
     
172. DANDEL M
     It is time to think about further optimization of the echocardiographic assessment of left ventricular responses to mitral regurgitation.
     Int J Cardiol. 2024 Feb 9:131841. doi: 10.1016/j.ijcard.2024.131841.
     PubMed    
     
     
     
173. KWAK S, Lee HJ, Lee H, Park JB, et al
     Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;396:131574.
     PubMed     Abstract available
     
     
     January 2024
174. KURASAWA S, Imaizumi T, Kondo T, Hishida M, et al
     Relationship between peak aortic jet velocity and progression of aortic stenosis in patients undergoing hemodialysis.
     Int J Cardiol. 2024 Jan 30:131822. doi: 10.1016/j.ijcard.2024.131822.
     PubMed     Abstract available
     
     
     
175. ELKOUMY A, Ruck A, Abdel-Wahab M, Thiele H, et al
     ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2.
     Int J Cardiol. 2024 Jan 19:131792. doi: 10.1016/j.ijcard.2024.131792.
     PubMed     Abstract available
     
     
     
176. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
     Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
     Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
     PubMed     Abstract available
     
     
     
177. CARABETTA N, Siller-Matula JM, Boccuto F, Panuccio G, et al
     Commissural alignment during TAVR reduces the risk of overlap to coronary ostia.
     Int J Cardiol. 2024;395:131572.
     PubMed     Abstract available
     
     
     
178. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
     The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre.
     Int J Cardiol. 2024;395:131416.
     PubMed     Abstract available
     
     
     
179. DEL FRANCO A, Biagioni G, Mazzoni C, Cappelli F, et al
     Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact.
     Int J Cardiol. 2024;395:131413.
     PubMed    
     
     
     
180. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
     Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
     Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
     PubMed     Abstract available
     
     
     
181. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
     Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
     Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
     PubMed     Abstract available
     
     
     
182. LERMAN TT, Levi A, Kornowski R
     Response to: "Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond".
     Int J Cardiol. 2024 Jan 5:131751. doi: 10.1016/j.ijcard.2024.131751.
     PubMed    
     
     
     
183. VAN WELY M, van Nieuwkerk AC, Rooijakkers M, van der Wulp K, et al
     Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.
     Int J Cardiol. 2024;394:131353.
     PubMed     Abstract available
     
     
     December 2023
184. MOSCARELLA E, Ielasi A, Montonati C, Pellegrini D, et al
     Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.
     Int J Cardiol. 2023 Dec 31:131701. doi: 10.1016/j.ijcard.2023.131701.
     PubMed     Abstract available
     
     
     
185. ANWER S, Nussbaum S, Winkler NE, Benz DC, et al
     Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation.
     Int J Cardiol. 2023 Dec 29:131660. doi: 10.1016/j.ijcard.2023.131660.
     PubMed     Abstract available
     
     
     
186. HIRAM R
     The duration of atrial fibrillation might be associated with right heart disease severity.
     Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
     PubMed    
     
     
     
187. ANTIA A, Pius R, Ndukauba C, Zarauz VR, et al
     Temporal trends in the utilization and outcome of transcatheter aortic valve replacement across racial and ethnic groups. A nationwide analysis.
     Int J Cardiol. 2023 Dec 22:131669. doi: 10.1016/j.ijcard.2023.131669.
     PubMed     Abstract available
     
     
     
188. CAETANO L DA SILVA, Gibicoski TB, Rodriguez F, Scabello I, et al
     Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.
     Int J Cardiol. 2023 Dec 22:131670. doi: 10.1016/j.ijcard.2023.131670.
     PubMed     Abstract available
     
     
     
189. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
     Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
     Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
     PubMed     Abstract available
     
     
     
190. IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
     Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
     Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
     PubMed     Abstract available
     
     
     
191. BOLETI OD, Roussos S, Norrish G, Field E, et al
     Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
     Int J Cardiol. 2023;393:131405.
     PubMed     Abstract available
     
     
     
192. OZLEK B
     Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
     Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
     PubMed    
     
     
     
193. GOZDEK M, Kowalewski M
     Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond.
     Int J Cardiol. 2023 Dec 8:131647. doi: 10.1016/j.ijcard.2023.131647.
     PubMed    
     
     
     
194. SEE C, Wang Y, Yang Y, Tirziu D, et al
     Impact of sex on transcatheter aortic valve replacement outcomes: Results of a single-center study.
     Int J Cardiol. 2023 Dec 6:131643. doi: 10.1016/j.ijcard.2023.131643.
     PubMed     Abstract available
     
     
     
195. HOLIEROOK M, Henstra MJ, Dolman DJ, Chekanova EV, et al
     Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
     Int J Cardiol. 2023 Dec 6:131637. doi: 10.1016/j.ijcard.2023.131637.
     PubMed     Abstract available
     
     
     
196. MATTIG I, Steudel T, Barzen G, Frumkin D, et al
     Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease.
     Int J Cardiol. 2023 Dec 3:131629. doi: 10.1016/j.ijcard.2023.131629.
     PubMed     Abstract available
     
     
     November 2023
197. FERNANDEZ-GOLFIN C, Gonznalez-Gomez A
     Unmasking tricuspid regurgitation.
     Int J Cardiol. 2023 Nov 28:131609. doi: 10.1016/j.ijcard.2023.131609.
     PubMed    
     
     
     
198. KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
     Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
     Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
     PubMed     Abstract available
     
     
     
199. CHAN J, Narayan P, Fudulu DP, Dong T, et al
     Trend in mitral valve prostheses of choice and early outcomes in the United Kingdom.
     Int J Cardiol. 2023 Nov 25:131607. doi: 10.1016/j.ijcard.2023.131607.
     PubMed     Abstract available
     
     
     
200. HAUGE SW, Estensen ME, Persson R, Abebe S, et al
     The importance of concomitant mitral regurgitation for estimates of mitral valve area by pressure half time in patients with chronic rheumatic heart disease.
     Int J Cardiol. 2023 Nov 21:131600. doi: 10.1016/j.ijcard.2023.131600.
     PubMed     Abstract available
     
     
     
201. MOSCARELLI M, Sollami G, Lentini E, Prestera R, et al
     About different localization of hypoattenuated lesions following transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Nov 16:131597. doi: 10.1016/j.ijcard.2023.131597.
     PubMed     Abstract available
     
     
     
202. HU D, Lan T, Chen Y, Chen L, et al
     An 18-year evolution of congenital heart disease in China: An echocardiographic database-based study.
     Int J Cardiol. 2023;391:131286.
     PubMed     Abstract available
     
     
     
203. KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
     Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
     Int J Cardiol. 2023;391:131265.
     PubMed     Abstract available
     
     
     
204. WU Z, Nie C, Zhu C, Meng Y, et al
     Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy.
     Int J Cardiol. 2023;391:131266.
     PubMed     Abstract available
     
     
     
205. DE SARRO R, Sabatino J
     Left atrial function's evaluation in aortic stenosis: A clinical imperative.
     Int J Cardiol. 2023 Nov 11:131579. doi: 10.1016/j.ijcard.2023.131579.
     PubMed    
     
     
     
206. LOSI MA, Monda E, Lombardi R, Lioncino M, et al
     Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
     PubMed     Abstract available
     
     
     
207. ZHOU N, Liu A, Weng H, Liu W, et al
     Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers.
     Int J Cardiol. 2023 Nov 8:131576. doi: 10.1016/j.ijcard.2023.131576.
     PubMed     Abstract available
     
     
     
208. DORES H, Toste A, Cardim N
     Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
     Int J Cardiol. 2023;390:131260.
     PubMed     Abstract available
     
     
     
209. SALA A, Alfieri O
     Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
     Int J Cardiol. 2023;390:131146.
     PubMed    
     
     
     
210. NEMES A
     Three-dimensional echocardiography for Tricuspid Annulus - Transthoracic or transoesophageal approach?
     Int J Cardiol. 2023;390:131170.
     PubMed    
     
     
     October 2023
211. BRANDES A
     Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
     Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
     PubMed    
     
     
     
212. LIU Z, Wei P, Jiang H, Zhang F, et al
     Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019.
     Int J Cardiol. 2023 Oct 30:131561. doi: 10.1016/j.ijcard.2023.131561.
     PubMed     Abstract available
     
     
     
213. MOSCARELLI M, Prestera R, Fiore C, Pernice V, et al
     Evaluation of the anatomic sinus after transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Oct 20:131551. doi: 10.1016/j.ijcard.2023.131551.
     PubMed     Abstract available
     
     
     
214. HOU Q, Wu W, Fang L, Zhang X, et al
     Patient-specific computational fluid dynamics for hypertrophic obstructive cardiomyopathy.
     Int J Cardiol. 2023;389:131263.
     PubMed     Abstract available
     
     
     
215. BADWAN O, Mirzai S, Skoza W, Hawk F, et al
     Clinical outcomes following tricuspid transcatheter edge-to-edge repair with PASCAL: A meta-analysis.
     Int J Cardiol. 2023;389:131194.
     PubMed     Abstract available
     
     
     
216. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
     Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
     Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
     PubMed     Abstract available
     
     
     
217. BHOGAL S, Waksman R, Shea C, Zhang C, et al
     Self-expanding and balloon-expandable valves in low risk TAVR patients.
     Int J Cardiol. 2023 Oct 12:131431. doi: 10.1016/j.ijcard.2023.131431.
     PubMed     Abstract available
     
     
     
218. MYAGMARDORJ R, Stassen J, Nabeta T, Hirasawa K, et al
     Impact of chronic obstructive pulmonary disease on right ventricular function and remodeling after aortic valve replacement.
     Int J Cardiol. 2023 Oct 5:131414. doi: 10.1016/j.ijcard.2023.131414.
     PubMed     Abstract available
     
     
     
219. CHEN X
     The real world of stroke incidence in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2023;388:131172.
     PubMed    
     
     
     
220. MARTIN M, Moris C
     Subclinical leaflet thrombosis after TAVI: To be or not to be.
     Int J Cardiol. 2023;388:131140.
     PubMed    
     
     
     September 2023
221. YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
     Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
     Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
     PubMed     Abstract available
     
     
     
222. WINKLER NE, Anwer S, Rumpf PM, Tsiourantani G, et al
     Left atrial pump strain predicts long-term survival after transcatheter aortic valve implantation.
     Int J Cardiol. 2023 Sep 28:131403. doi: 10.1016/j.ijcard.2023.131403.
     PubMed     Abstract available
     
     
     
223. CHANG WT, Lin CH, Lee WC, Kan WC, et al
     Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome.
     Int J Cardiol. 2023 Sep 17:131367. doi: 10.1016/j.ijcard.2023.131367.
     PubMed     Abstract available
     
     
     
224. KHARBANDA RK, Ramdat Misier NL, Van den Eynde J, El Mathari S, et al
     Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
     Int J Cardiol. 2023;387:131099.
     PubMed     Abstract available
     
     
     
225. SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
     Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
     Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
     PubMed     Abstract available
     
     
     
226. LEOW R, Kong WKF, Li TY, Poh KK, et al
     Yeo's index: A novel index that combines anatomic and haemodynamic assessment of the severity of mitral stenosis.
     Int J Cardiol. 2023 Sep 7:131350. doi: 10.1016/j.ijcard.2023.131350.
     PubMed     Abstract available
     
     
     
227. HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
     Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
     Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
     PubMed     Abstract available
     
     
     
228. YAMAZAKI C, Higuchi R, Saji M, Takamisawa I, et al
     Discrepancy between invasive and echocardiographic transvalvular gradient after TAVI: Insights from the LAPLACE-TAVI registry.
     Int J Cardiol. 2023;386:17-23.
     PubMed     Abstract available
     
     
     August 2023
229. GENTILE F, Buoncristiani F, Sciarrone P, Bazan L, et al
     Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation.
     Int J Cardiol. 2023 Aug 19:131272. doi: 10.1016/j.ijcard.2023.131272.
     PubMed     Abstract available
     
     
     
230. LI S, Fang L, Wu W, Zhang Z, et al
     Echocardiographic diagnosis of rupture of mitral valve papillary muscle.
     Int J Cardiol. 2023 Aug 18:131273. doi: 10.1016/j.ijcard.2023.131273.
     PubMed     Abstract available
     
     
     
231. PIERONI M, Ciabatti M, Bolognese L
     Stroke in hypertrophic cardiomyopathy. Never mind the rhythm.
     Int J Cardiol. 2023;385:41-42.
     PubMed    
     
     
     
232. NEMES A
     The tricuspid annulus in repaired tetralogy of Fallot - what does it play and what does it not?
     Int J Cardiol. 2023;385:22.
     PubMed    
     
     
     July 2023
233. SISINNI A, Estevez-Loureiro R
     The K-clip: Time for a new tricuspid valve focal annuloplasty system.
     Int J Cardiol. 2023 Jul 31:131234. doi: 10.1016/j.ijcard.2023.131234.
     PubMed    
     
     
     
234. BARKI M, Ielasi A, Buono A, Maffeo D, et al
     Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.
     Int J Cardiol. 2023 Jul 31:131236. doi: 10.1016/j.ijcard.2023.131236.
     PubMed     Abstract available
     
     
     
235. SANCHIS L, Farrero M
     Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
     Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
     PubMed    
     
     
     
236. MIRZAI S, Aleixo GFP, Mazumder S, Berglund F, et al
     Sarcopenia evaluation on cardiac magnetic resonance imaging in older adults for outcomes prediction following surgical aortic valve replacement.
     Int J Cardiol. 2023 Jul 25:131216. doi: 10.1016/j.ijcard.2023.131216.
     PubMed     Abstract available
     
     
     
237. BHOGAL S, Rogers T, Merdler I, Reddy P, et al
     Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Jul 19:131196. doi: 10.1016/j.ijcard.2023.131196.
     PubMed     Abstract available
     
     
     
238. ZHANG X, Jin Q, Pan W, Li W, et al
     First-in-human study of the K-Clip transcatheter annular repair system for severe functional tricuspid regurgitation.
     Int J Cardiol. 2023 Jul 11:131174. doi: 10.1016/j.ijcard.2023.131174.
     PubMed     Abstract available
     
     
     
239. CHATTERJEE A, Kazui T, Acharya D
     Growing prevalence of aortic stenosis - Question of age or better recognition?
     Int J Cardiol. 2023 Jul 8:131155. doi: 10.1016/j.ijcard.2023.131155.
     PubMed    
     
     
     
240. XU Z, Dai XF, Lin F, Chen LW, et al
     Two-incision totally thoracoscopic mitral valve repair combined with radiofrequency atrial fibrillation ablation in rheumatic mitral valve disease: Early results of a case series of 43 consecutive patients.
     Int J Cardiol. 2023 Jul 8:131158. doi: 10.1016/j.ijcard.2023.131158.
     PubMed     Abstract available
     
     
     
241. MASSERA D, Sherrid MV, Maron MS, Rowin EJ, et al
     How common is hypertrophic cardiomyopathy... really?: Disease prevalence revisited 27 years after CARDIA.
     Int J Cardiol. 2023;382:64-67.
     PubMed     Abstract available
     
     
     
242. SA MP, Tasoudis P, Jacquemyn X, Van den Eynde J, et al
     Long-term outcomes of valve-sparing root versus composite valve graft replacement for acute type A aortic dissection: Meta-analysis of reconstructed time-to-event data.
     Int J Cardiol. 2023;382:12-19.
     PubMed     Abstract available
     
     
     June 2023
243. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
     The long-term clinical course of moderate tricuspid regurgitation.
     Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
     PubMed     Abstract available
     
     
     
244. LIND A, Esfahan MA, Totzeck M, Al-Rashid F, et al
     Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.
     Int J Cardiol. 2023 Jun 22:131130. doi: 10.1016/j.ijcard.2023.131130.
     PubMed     Abstract available
     
     
     
245. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
     2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
     Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
     PubMed     Abstract available
     
     
     
246. LEE M, Shechter A, Han D, Nguyen LC, et al
     Left ventricular morphologic progression in apical hypertrophic cardiomyopathy.
     Int J Cardiol. 2023;381:62-69.
     PubMed     Abstract available
     
     
     
247. BOURG C, Curtis E, Donal E
     Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation.
     Int J Cardiol. 2023 Jun 12:S0167-5273(23)00881.
     PubMed    
     
     
     
248. RAHIMI M, Kpodonu J
     Myectomy or myomectomy, that is the question.
     Int J Cardiol. 2023;380:28.
     PubMed    
     
     
     
249. SCHEFFERS LE, Kok R, van den Berg LE, van den Hout JMP, et al
     Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease.
     Int J Cardiol. 2023;380:65-71.
     PubMed     Abstract available
     
     
     May 2023
250. FERSTL P, Achenbach S, Marwan M, Bittner DO, et al
     Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI).
     Int J Cardiol. 2023 May 25:S0167-5273(23)00727.
     PubMed     Abstract available
     
     
     
251. ZHOU Y, Lin X, Zhu Q, Li H, et al
     Association between trajectories in cardiac damage and clinical outcomes after transcatheter aortic valve replacement.
     Int J Cardiol. 2023 May 11:S0167-5273(23)00707.
     PubMed     Abstract available
     
     
     
252. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
     Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
     Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
     PubMed     Abstract available
     
     
     
253. EGBE AC, Miranda WR, Anderson JH, Pellikka PA, et al
     Left ventricular adaptation to aortic regurgitation in adults with repaired coarctation of aorta.
     Int J Cardiol. 2023 May 4:S0167-5273(23)00650.
     PubMed     Abstract available
     
     
     April 2023
254. AMBROSY AP, Go AS, Leong TK, Garcia EA, et al
     Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.
     Int J Cardiol. 2023 Apr 27:S0167-5273(23)00601.
     PubMed     Abstract available
     
     
     
255. SHOJI S, Kuno T, Malik A, Briasoulis A, et al
     Association between institutional volume of transcatheter mitral valve repair and readmission rates: A report from the National Readmission Database.
     Int J Cardiol. 2023 Apr 19:S0167-5273(23)00588.
     PubMed     Abstract available
     
     
     
256. FUMAGALLI C, Bonanni F, Beltrami M, Ruggieri R, et al
     Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
     Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523.
     PubMed     Abstract available
     
     
     
257. LEIBOWITZ D, Yoshida Y, Jin Z, Nakanishi K, et al
     Factors associated with the progression of aortic valve calcification in older adults.
     Int J Cardiol. 2023 Apr 6:S0167-5273(23)00470.
     PubMed     Abstract available
     
     
     
258. ELKOUMY A, Jose J, Gunasekaran S, Kumar A, et al
     Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication.
     Int J Cardiol. 2023 Apr 5:S0167-5273(23)00516.
     PubMed     Abstract available
     
     
     
259. MERLO M, Folgheraiter A, Sinagra G
     Evolving mortality and clinical scenarios in HCM: Where are we?
     Int J Cardiol. 2023;376:97-99.
     PubMed    
     
     
     March 2023
260. MENG H, Zhao X, Wang JD, Wan LY, et al
     Comparison between multimodality imaging approaches for measurement of the tricuspid annulus in severe tricuspid regurgitation.
     Int J Cardiol. 2023 Mar 31:S0167-5273(23)00434.
     PubMed     Abstract available
     
     
     
261. DE MARZO V, Viglino U, Zecchino S, Matos JG, et al
     Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study.
     Int J Cardiol. 2023 Mar 29:S0167-5273(23)00464.
     PubMed     Abstract available
     
     
     
262. MENDEL B, Kohar K, Amirah S, Vidya AP, et al
     The outcomes of fetal aortic valvuloplasty in critical aortic stenosis: A systematic review and meta-analysis.
     Int J Cardiol. 2023 Mar 28:S0167-5273(23)00461.
     PubMed     Abstract available
     
     
     
263. ESPOSITO G, Montalto C, Crimi G, Grippo R, et al
     Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE registry).
     Int J Cardiol. 2023 Mar 8:S0167-5273(23)00336.
     PubMed     Abstract available
     
     
     February 2023
264. LEONE PP, Gohar A, Pagnesi M, Mangieri A, et al
     Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison.
     Int J Cardiol. 2023 Feb 28:S0167-5273(23)00270.
     PubMed     Abstract available
     
     
     
265. MALTES S, Abecasis J, Santos RR, Lopes P, et al
     LGE prevalence and patterns in severe aortic stenosis: When "junctional" means the same.
     Int J Cardiol. 2023 Feb 22:S0167-5273(23)00250.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.